Sinus of Valsalva safe site for ablation in some patients

The sinus of Valsalva is a safe and effective site to ablate in patients with atrial and ventricular tachycardias, study results suggested.

Researchers from the Academic Hospital of the University of Freiburg in Germany enrolled 21 patients with ectopic atrial tachycardia (n=6) and ventricular tachycardia/premature ventricular complexes (n=15) into the study.

The aortic wall structure of the patients was assessed using transesophageal echocardiography and MRI.

According to the researchers, aortic wall integrity was confirmed in all patients by transesophageal echocar...
FULL STORY

Calendar
December 10, 2008
EUROECHO 12th Annual Meeting of the European Association of Echocardiography
Lyon, France
more information>>

December 7, 2008
Innovations in Cardiovascular Interventions
Tel Aviv, Israel
more information>>

December 3, 2008
7th International Course on Carotid Angioplasty and Other Crebrovascular Interventions
Frankfurt, Germany
more information>>

QUOTE OF THE WEEK

"The formation of ICUS is a truly historic development in this field...."


Joint Commission issues recommendations for anticoagulation therapy, safety

The Joint Commission issued a Sentinel Event Alert and held a press conference to address the safety of anticoagulant therapy. The alert offers recommendations and information about medication errors and the drug-related risks of heparin, warfarin and low–molecular-weight heparin. “This alert brings attention to the issues of medication errors, specifically the anticoagulation errors, and these errors are preventable,” said Peter Angood, MD, vice president and chief patient safety officer of The Joint Commission, during the press conference. According to the alert, unfractiona...

FULL STORY
Cardiology today Trial Scorecards
Cardiology today Trial Scorecards